Danish Ahmed

About

Danish Ahmed completed his Doctor of Philosophy in Pharmaceutical Sciences from SHIATS-Deemed University (Formerly Allahabad Agricultural Institute) in 2015. Further, Danish Ahmed received his M Pharm degree from the Jamia Hamdard University, New Delhi, India, where he was later appointed as Principal Investigator for work on diabetes mellitus at the National Pharmacology Library of Hamdard University, Delhi, India. Later in 2008 he was appointed as Senior Research Officer in World Health Organization (WHO), New Delhi, India, where he spent 9 months on a diabetes project. After completing his tenure in WHO he became an Assistant Professor in pharmacology at the Sam Higginbottom Institute of Agriculture & Technology (SHIATS), Deemed University, Allahabad, India. He was awarded as best orator in pharmacology section at the 61st Indian Science Congress (ISC), Trivandrum, India. He is on-board reviewer of various national and international journals.

Employment

• Sam Higginbottom Institute of Agriculture Technology and Sciences Faculty of Health Sciences Assistant Professor (Pharmacology)
  2009 - Present

Education

• Sam Higginbottom Institute of Agriculture Technology and Sciences Faculty of Health Sciences Doctor of Philosophy
  2011 - 2015
• Jamia Hamdard Faculty of Pharmacy Master of Pharmacy
  2006 - 2008
• Jamia Hamdard Faculty of Pharmacy Bachelor of Pharmacy
  2002 - 2006
• Chaudhary Charan Singh University Bachelor of Science (CBZ)
  1997 - 2000

Projects & Funding

Projects & funding information is unavailable.

Publications (9)

• Improved glycemic control, pancreas protective and hepatoprotective effect by traditional poly-herbal formulation
  2013 DOI: 10.1186/1472-6882-13-10
  +Save
• Anti-diabetic, anti-oxidant and anti-hyperlipidemic activities of Melastoma malabathricum Linn. leaves in streptozotocin induced diabetic rats
  2013 DOI: 10.1186/1472-6882-13-222
  +Save
• Molecular docking research analysis of novel natural and synthetic PTP 1B inhibitors as potential therapeutic target for diabetes mellitus
  2013 DOI: 10.1530/endoabs.32.p496
  +Save
• Umbelliferone beta-D-galactopyranoside from Aegle marmelos (L.) corr. an ethnomedicinal plant with antidiabetic, antihyperlipidemic and antioxidative activity
  2013 DOI: 10.1186/1472-6882-13-273
  +Save
• Inhaled Insulin: Intrapulmonary or Intranasal?
  2012 DOI: 10.1038/npre.2012.7115.1
  +Save
• An emerging protagonist: Sodium Glucose Co-transporters (SGLTs) as a burgeoning target for the treatment of diabetes mellitus
  2012 DOI: 10.1038/npre.2012.7057
  +Save
• The effects of triple vs. dual and monotherapy with rosiglitazone, glimepiride, and atorvastatin on lipid profile and glycemic control in type 2 diabetes mellitus rats
  2011 DOI: 10.1111/j.1472-8206.2011.00960.x
  +Save
• Letter to editor regarding the article by Saraogi et al
  2011 DOI: 10.1016/j.biomag.2011.09.003
  +Save
• Cyclin-Dependent Kinase 5/p35/p39: A Novel and Imminent Therapeutic Target for Diabetes Mellitus
  2011 DOI: 10.1155/2011/530274
  +Save